EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical Evaluation of Puerarin as a Modulator of Metabolic and Inflammatory Parameters in a High-Fat-Diet-Fed Mice Model

Luisa Guadalupe Camacho-Padilla, Adelaida Sara Minia Zepeda-Morales, Javier Arrizon iD, Mario Eduardo Flores-Soto iD, José Sergio Zepeda-Nuño iD, Lucrecia Carrera-Quintanar iD, Azucena Herrera-González iD, Gerardo Aparicio-García, Rocío Ivette López-Roa iD

Molecules · 2025

DOI: 10.3390/molecules30193895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Luisa Guadalupe Camacho-Padilla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigación y Desarrollo Farmacéutico, Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Univ…. Hauptthemen laut MEDLINE: Isoflavones, Diet, High-Fat, Obesity, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Guadalajara, CONACyT-México.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a multifactorial condition characterized by adipose tissue dysfunction, insulin resistance, and low-grade systemic inflammation, contributing to metabolic disturbances. The search for natural compounds with protective actions against obesity and its complications has attracted increasing attention. Puerarin, an isoflavone derived from Pueraria lobata, has been reported to exert anti-inflammatory and metabolic regulatory properties. This study aimed to evaluate the effects of puerarin, a natural isoflavone, on metabolic and inflammatory alterations in a mouse model of diet-induced obesity. Male C57BL/6 mice were fed a high-fat diet (HFD) and treated orally with puerarin (50 mg/kg) for 14 weeks. The administration of puerarin resulted in a 17% reduction in weight gain, improved glucose tolerance by 6.2%, and decreased insulin resistance by 11% compared to the HFD group. Histological analysis revealed a marked reduction in hepatic steatosis and adipocyte hypertrophy. Additionally, puerarin lowered the concentration of proinflammatory cytokines, including IL-6, TNF-α, IL-1β, IL-17A, and IFN-γ, while increasing IL-10 levels. These findings suggest that puerarin may provide protective effects on glucose metabolism, liver steatosis, and adipose tissue inflammation in obesity, highlighting its possible potential as an immunometabolic modulator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesDiet, High-FatObesityInflammationAnimalsMiceMaleInsulin ResistanceDisease Models, AnimalCytokinesMice, Inbred C57BLAdipose Tissue

Stichwörter der Autor:innen

adipose tissue inflammationmetabolic dysfunctionobesitypuerarin

Substanzen

puerarinIsoflavonesCytokines

Autor:innen und Institutionen

  • Laboratorio de Investigación y Desarrollo Farmacéutico, Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico.
  • Laboratorio de Análisis Clínicos e Investigación Traslacional, Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico.
  • Biotecnología Industrial, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. Unidad Zapopan, Zapopan 45019, Jalisco, Mexico.
  • Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social, Guadalajara 44160, Jalisco, Mexico.
  • Departamento de Microbiología y Patología, Centro de Investigación y Diagnóstico de Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44350, Jalisco, Mexico.
  • Doctorado en Ciencias de la Nutrición Traslacional, Departamento de Alimentación y Nutrición, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.

ORCID-Profile: Javier Arrizon, Mario Eduardo Flores-Soto, José Sergio Zepeda-Nuño, Lucrecia Carrera-Quintanar, Azucena Herrera-González, Rocío Ivette López-Roa

Förderung

  • Universidad de Guadalajara
  • CONACyT-México

Zitieren

APA

Camacho-Padilla, L. G., Zepeda-Morales, A. S. M., Arrizon, J., Flores-Soto, M. E., Zepeda-Nuño, J. S., Carrera-Quintanar, L., Herrera-González, A., Aparicio-García, G., & López-Roa, R. I. (2025). Preclinical Evaluation of Puerarin as a Modulator of Metabolic and Inflammatory Parameters in a High-Fat-Diet-Fed Mice Model. Molecules. https://doi.org/10.3390/molecules30193895

Vancouver

Camacho-Padilla LG, Zepeda-Morales ASM, Arrizon J, Flores-Soto ME, Zepeda-Nuño JS, Carrera-Quintanar L, et al. Preclinical Evaluation of Puerarin as a Modulator of Metabolic and Inflammatory Parameters in a High-Fat-Diet-Fed Mice Model. Molecules. 2025. doi:10.3390/molecules30193895

BibTeX
@article{CamachoPadilla2025,
  author = {Camacho-Padilla, Luisa Guadalupe and Zepeda-Morales, Adelaida Sara Minia and Arrizon, Javier and Flores-Soto, Mario Eduardo and Zepeda-Nuño, José Sergio and Carrera-Quintanar, Lucrecia and Herrera-González, Azucena and Aparicio-García, Gerardo and López-Roa, Rocío Ivette},
  title = {Preclinical Evaluation of Puerarin as a Modulator of Metabolic and Inflammatory Parameters in a High-Fat-Diet-Fed Mice Model},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30193895}
}
Kostenlos starten →